Cortigent, Inc. (CRGT)
| Market Cap | 65.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.60M |
| Shares Out | 6.50M |
| EPS (ttm) | -1.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CRGT
Cortigent, through its predecessor Second Sight Medical Products, Inc., is a pioneer in developing targeted neurostimulation systems to help patients recover critical body functions. Our technology combines advanced neuroscience with proprietary microelectronics, software, and data processing capabilities to provide artificial vision and potentially restore muscle movement. Our first commercial system, “Argus II,” was approved by the U.S. Food & Drug Administration under a Humanitarian Device Exemption and has provided artificial vision to hund... [Read more]
Financial Performance
Financial StatementsNews
U.S. IPO Weekly Recap: Oil And Gas Well Equipment Provider Flowco Debuts, While More Sizable Deals Join The Pipeline
Three IPOs and three SPACs were listed this week. Eight issuers submitted initial filings this week, including a handful of sizable names. The US IPO market is set to host a historic event in the week...
U.S. IPO Weekly Recap: Flowco Launches First Major IPO Of 2025 As Smithfield, Others Join The Pipeline
Three very small Asian issuers and one blank check company listed in the US this past week, though the biggest headlines came from a sizable launch and notable new filings. Energy equipment and servic...
U.S. IPO Weekly Recap: 2 Microcaps List As More Small Issuers File For Listings
Two small IPOs listed this week - INLIF and OneConstruction Group. Five issuers and two SPACs submitted initial filings this week. The 2025 IPO market is here, and while there are a few small deals on...
IPO Update: Cortigent Readies $15 Million Mini-IPO
Cortigent, Inc. has filed proposed terms for a $15 million U.S. IPO. The firm is developing neurostimulation technologies to treat profound blindness and potentially other conditions. Cortigent is a t...
Cortigent Seeks $17 Million U.S. IPO For Orion Neurostimulation Device Development
Cortigent has filed to raise $17 million in a U.S. IPO, although the final amount may differ. The firm is developing a neurostimulation device to assist profoundly blind persons.
Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division
Vivani Medical, Inc. (NASDAQ: VANI), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, today announced the filing of a Registration Statement...
Visual prosthetics developer Cortigent files for a $17 million IPO
Cortigent, a visual prosthetics developer being spun out of Vivani Medical, filed on Monday with the SEC to raise up to $17 million in an initial public offering.
Cortigent IPO Registration Document (S-1)
Cortigent has filed to go public with an IPO on the NASDAQ.